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Abstract ATP in the 100 μM-1 mM concentration range
provoked a calcium-independent increase of the oxidation of
dichlorodihydrofluorescein (DCFH) to dichlorofluorescein
(DCF) by mouse submandibular cells. 3′-O-(4-benzoyl)
benzoyl adenosine 5′-triphosphate (BzATP), a P2X7 agonist,
but not a muscarinic or an adrenergic agonist, reproduced the
effect of ATP. The inhibition of phospholipase C by U73122
or the potentiation of P2X4 receptor activation with ivermectin
did not modify the response to ATP. ATP did not increase the
oxidation of DCFH in cells isolated from submandibular
glands of P2X7 knockout mice or in cells pretreated with a
P2X7 antagonist. The inhibition of protein kinase C or of
mitogen-activated protein kinase (MAP kinase) or of reduced
nicotinamide adenine dinucleotide phosphate (NADPH) oxi-
dase blocked the oxidation of DCFH without affecting the
increase of the intracellular concentration of calcium or the
uptake of ethidium bromide in response to extracellular ATP.
From these results it is concluded that the activation of the
P2X7 receptors from submandibular glands triggers an in-
tracellular signalling cascade involving protein kinase C and
MAP kinase leading to the stimulation of NADPH oxidase
and the subsequent generation of reactive oxygen species.
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Abbreviations
ROS reactive oxygen species
DCFH 2′,7′-dichlorodihydrofluorescein
DCF 2′,7′-dichlorofluorescein
MAP
kinase
mitogen-activated protein kinase
AEBSF 4-(2-aminoethyl)benzenesulfonyl fluoride
DPI diphenyleneiodonium chloride
BzATP 3′-O-(4-benzoyl)benzoyl adenosine 5′-triphosphate
oATP adenosine 5′-triphosphate 2′,3′-dialdehyde
KN-62 (1-[N,O-bis-(5-isoquinolinesulfonyl)-N-methyl-
L-tyrosyl]-4-phenylpiperazine)
FCCP carbonylcyanide-4-(trifluoromethoxy)-
phenylhydrazone
Introduction
The production of reactive oxygen is a major response to
invading micro-organisms [1]. Phagocytic cells express a
reduced nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase (phox) which translocates to the mem-
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La Jolla, CA 92093-0651, USAbrane when it is activated [2]. The enzymatic complex
generates superoxide, the precursor of reactive oxygen
species (ROS). These ROS contribute to the protection of
the interior milieu and to the killing of invading pathogens:
a deficit of phox activity provokes the chronic granuloma-
tous disease, an inherited disease characterized by an
increased sensitivity to microbial infections [3]. Among
phagocytic cells, macrophages are a major source of ROS.
They produce ROS not only after exposure to a pathogen
but also in response to extracellular ATP [4, 5]. Non-
phagocytic cells can also produce ROS [6]. Geiszt et al. [7]
suggested that the release of ROS by exocrine glands might
have a protective role and prevent the colonization of the
lumen of these glands by bacteria. Salivary glands are at the
ostium of the digestive tract. The production of saliva is
essential for the maintenance of the integrity of the oral
mucosa. Xerostomia is frequently associated with oral
cancers and with recurrent infections of the oral cavity
[8]. This is best explained by the composition of the saliva.
This exocrine secretion contains not only salts and digestive
enzymes (like kallikrein or amylase and lipase) but also
IgA, cystatins, histatins, peroxidase, lactoferrin or lyso-
zyme, proteins which have fungicidal, bactericidal or
viricidal properties [9]. The production of ROS by these
glands might also be a mechanism of defence against
infections but has never been extensively studied. We and
others have demonstrated that the ductal and acinar cells
from these glands express various types of purinergic
receptors [10, 11]. The purpose of our work was to test
for the possible production of ROS by submandibular
salivary glands in response to purinergic agonists. Our
results show that the P2X7 receptor is coupled to the
production of ROS by a mechanism involving protein
kinase C and mitogen-activated protein (MAP) kinase and
the activation of NADPH oxidase.
Materials and methods
The experiments were carried out on C57Bl/6J P2X7R
+/+
mice (wild-type, WT) (Charles River Laboratories, Worces-
ter, MA, USA) and P2X7R
-/- (knockout, KO mice) kindly
supplied by Pfizer Inc. (Groton, CT, USA). Breeding of
P2X7 KO mice males with females was used to maintain
the colony of receptor-deficient animals. Mice used in the
experiments were between 20 and 25 g (12–16 weeks of
age). The expression of P2X7 receptors in WT mice and its
absence in KO mice were tested by Western blot as
previously described [12]. The animals were fed ad libitum
and had free access to water. The care and use of the
animals involved in this study was approved by the Belgian
Ministry of Agriculture in agreement with European
regulations.
LY294002, PD98059 and bisindolylmaleimide (BIM)
were purchased from Calbiochem (VWR, Leuven, Bel-
gium). The 2′,7 ′-dichlorodihydrofluorescein diacetate
(DCFH DA), fura-2/AM and ethidium bromide were from
Invitrogen (Groningen, Netherlands). Allopurinol, 4-(2-
aminoethyl)benzenesulfonyl fluoride (AEBSF), apocynin,
diphenyleneiodonium chloride (DPI), N-methylarginine, N-
acetylcysteine, thiourea, thapsigargin, ionomycin, cheler-
ythrine, 1-[6-[[17-β-3-methoxyestra-1,3,5(10)-trien-17-yl]
amino]hexyl]-1H-pyrrole-2,5-dione (U73122), 1-(6-((17b-
3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-2,5-
pyrrolidine-dione (U73343), adenosine 5′-triphosphate
2′,3′-dialdehyde (oATP), ethylene glycol-bis-(β-aminoethy-
lether)-N,N,N′,N′-tetraacetic acid (EGTA), N-[2-hydrox-
yethyl] piperazine-N′-[2-ethanesulfonic acid] (HEPES), (+)
and (-) isoproterenol, phorbol 12 myristate 13 acetate
(PMA) ivermectin and l-[N,O-bis(5-isoquinolinesulfonyl)-
N-methyl-L-tyrosyl]-4-phenylpiperazine (KN-62) were pur-
chased from Sigma (St. Louis, MO. USA). The bovine
serum albumin (BSA, fraction V) was from Roche
Diagnostics (Mannheim, Germany).
Preparation of the cellular suspension
The mice were killed with CO2. The submandibular glands
were immediately dissected and finely minced. The minced
tissue was digested in the presence of 0.4–0.5 U/ml of
collagenase P for 20 min at 37°C under constant shaking in
10 ml HEPES-buffered saline (HBS) medium containing
(mM): 24.5 HEPES (pH 7.4), 96 NaCl, 6 KCl, 1 MgCl2,
2.5 NaH2PO4, 11.5 glucose, 5 sodium pyruvate, 5 sodium
glutamate, 5 sodium fumarate, 1% (v/v) glutamine-free
amino acids mixture and 0.125% (w/v) BSA. Ten minutes
after the beginning of the digestion, the cells were aspirated
five times with 10-ml glass pipettes and further incubated
for 10 min. At the end of the digestion the crude suspension
was mechanically dispersed by gentle pipetting, filtered and
washed in 0.9% NaCl solution.
Assay of the intracellular production of ROS
The production of ROS was estimated with DCFH which
becomes fluorescent after oxidation to 2′,7′-dichlorofluor-
escein (DCF) by hydrogen peroxide, peroxyl radical or
peroxynitrite anion [13]. One-millilitre aliquots of the
cellular suspension from submandibular glands were
preincubated in the dark, at 25°C for at least 1 h in the
presence of 1 mM calcium and 1% (w/v) BSA and 6 μM
DCFH DA, a cell-permeant analog of DCFH. After this
incubation, 0.5 ml of the cellular suspension were washed
once with NaCl 0.9% and the cellular pellet was
resuspended in 2 ml HBS medium without BSA or
magnesium but with 1 mM calcium. The assay was
348 Purinergic Signalling (2008) 4:347–355performed at 25°C under constant stirring (SLM-Aminco
Bowman, Urbana, IL, USA). The samples were excited at
485 nm and the light emitted at 525 nm was measured
every second.
Assay of the intracellular concentration of calcium ([Ca
2+]i)
One-millilitre aliquots of the cellular suspension were
incubated in 2 ml HBS medium in the presence of
0.25 mM CaCl2 and 0.5% BSA. The suspension was
incubated for 45 min at 25°C in the presence of 2 μM fura-
2/AM. At the end of the incubation, the cells were washed
once with 10 ml isotonic NaCl. The pellet was resuspended
in 4 ml fresh HBS medium, in the absence of amino acids,
MgCl2 or BSA but in the presence of 1 mM CaCl2. The
calcium assay was performed at 25°C under constant
stirring on 2 ml of the cellular suspension. The excitation
wavelength was switched every second from 340 to 380 nm
and the light emitted at 510 nm was recorded. At the end of
the assay, the traces were calibrated with the successive
addition of 100 μM digitonin and 40 mM EGTA (pH 8.5
with tris). The autofluorescence measured after quenching
the fluorescence of the fura-2 by the addition of 100 mM
MnCl2 was subtracted from all the data before calculation
of the ratios. The calcium concentration was estimated by
the ratio method [14].
Measurement of the permeabilization of the plasma
membrane
The permeability of the plasma membrane was measured
with ethidium bromide which does not normally permeate
through the plasma membrane. Once inside the cells, the
salt which is non-fluorescent intercalates in double-stranded
nucleic acids and becomes fluorescent. The cells from two
submandibular glands were resuspended in 4 ml HBS
medium without calcium or magnesium. One-millilitre
aliquots were used for each measurement. Ethidium
bromide was added at a final concentration of 20 μM.
The cells were allowed to equilibrate for 5 min before the
beginning of the measurement which was performed at
37°C under constant stirring. The samples were excited
at 360 nm and the light emitted at 580 nm was measured
every second. At the end of the measurement, the maxi-
mum uptake was estimated by adding 100 μM digitonin
and the results were calculated taking this value as
reference.
Statistical analysis
The results were compared using the Mann-Whitney test
(n≤6) on the Student’s t-test (n>6).
Results
Purinergic receptor activation by ATP increases
the production of ROS
As shown in Fig. 1, cells from submandibular glands
preincubated with DCFH DA emitted light at 525 nm after
excitation at 485 nm. Under basal conditions, the fluores-
cence slightly increased with time. This increase was linear
for at least 10 min (Fig. 1). The addition of 1 mM ATP to
the cuvette provoked a rapid increase of the slope of the
curve: the rate of the increase of the fluorescence during the
120 s following the addition of 1 mM ATP was 2.6±0.2-
fold higher than the rate of the increase of fluorescence 60 s
before the addition of ATP. Considering that the increase of
the fluorescence was secondary to the oxidation of DCFH
to DCF, extracellular ATP probably increased the produc-
tion of ROS. In agreement with this hypothesis, 20 mM N-
acetylcysteine, which is a scavenger of ROS, inhibited the
increase of the fluorescence of DCF under basal conditions
from 992±64×10
−6 arbitrary fluorescence units (AFU) (n=
43) to 633±50×10
−6 AFU (n=15) in the presence of N-
acetylcysteine (P=0.043 when comparing the means using
a non-paired t-test). N-acetylcysteine fully abolished the
response to ATP when the nucleotide was added to the
medium 7 min after the start of the measurement (Fig. 2,
upper panel). N-Acetylcysteine partially inhibited the fast
but not the late increase of the [Ca
2+]i in response to ATP
Fig. 1 Effect of ATP on the oxidation of DCFH. Cells from
submandibular glands of WT (triangles)o rK O( circles) mice were
loaded with DCFH. After washing, the cells were resuspended in 2 ml
HBS medium in the absence of magnesium, in the presence of 1 mM
calcium and transferred in the cuvette of a spectrofluorimeter. The
fluorescence emitted at 525 nm after excitation at 485 nm was
measured every second. Two minutes after the start of the measure-
ment, some cells were exposed to 1 mM ATP (open symbols). Results
are expressed as arbitrary units of fluorescence and are the means ±
SEM of n experiments
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was specific for purinergic agonists (Fig. 3). Carbachol, an
agonist of muscarinic receptors, had no effect on the rate of
DCFH oxidation (n=5); (-) isoproterenol, a β-adrenergic
agonist, decreased the slope of the curve to 44±2% (n=6).
This inhibition was reproduced in two experiments with (+)
isoproterenol, the isomer inactive on adrenergic receptors
(34 and 46% inhibition in two experiments) but not by
forskolin, a general activator of adenylate cyclase (100±
4%, n=8). These results suggested that isoproterenol might
be a scavenger for ROS.
Characterization of the purinergic receptors involved
in the production of ROS
Salivary glands express both metabotropic (P2Y1 and
P2Y2) and ionotropic (P2X4 and P2X7) purinergic receptors
[10, 11]. To determine whether the receptor involved in the
production of ROS was a P2Y and/or a P2X receptor, the
cells were exposed to U73122, an inhibitor of phospholi-
pase C (PLC) or its analog, U73343, which has no effect on
PLC [15]. As shown in Fig. 3, these two aminosteroids did
not affect the response to ATP. In a next step we studied the
effect of ivermectin on the response to ATP. In subman-
dibular glands, this anti-parasite drug strongly potentiates
the response to P2X4 activation [12]. Ivermectin at a
100 μM concentration did not modify the production of
ROS in response to ATP (269±11%, n=4), suggesting that
P2X7 rather than P2X4 receptors triggered this response. As
shown in Fig. 4, concentrations of ATP higher than 100 μM
were required to observe a significant increase of the rate of
DCFH oxidation upon ATP stimulation. The P2X7 receptor
differs from the six other P2X receptors not only by its
structure (it has a long intracellular C-terminal domain
which is absent in the other P2X receptors) but also by the
fact that it has a very low sensitivity to ATP
4− [16]. The
response to ATP significantly dropped from 249±15%, n=
29, to 130±6%, n=4, P<0.01) following the addition of
magnesium to the medium which forms ATPMg
2− and
decreases the concentration of ATP
4− (Fig. 4). KN-62 and
Fig. 3 Effect of various agonists on the oxidation of DCFH by mouse
submandibular cells. Cells were treated as described in the legend to
Fig. 1. They were resuspended in HBS medium under control
conditions or in the presence of 10 μM U73122 or U73343. Two
minutes after the start of the measurement, the cells were exposed to
the mentioned agonists. The results are expressed as the ratio of the
slope of the curve after the addition of 1 mM ATP and the slope of the
curve before the addition of 1 mM ATP. Results are the means ± SEM
of n experiments. *P<0.05; ***P<0.005
Fig. 2 Effect of N-acetylcysteine on the response of mouse
submandibular glands to extracellular ATP. Upper panel: cells
preloaded with DCFH were resuspended in HBS medium in the
absence of magnesium and in the presence of 1 mM calcium and in
the absence (triangles) or in the presence (circles)o f2 0m MN-
acetylcysteine. Seven minutes after the start of the measurement the
cells were stimulated with 1 mM ATP. Results are expressed as
arbitrary units of fluorescence and are the means ± SEM of n
experiments. Lower panel: cells were preloaded with fura-2 and
resuspended in HBS medium in the absence of magnesium, in the
presence of 1 mM calcium and in the absence (triangles) or in the
presence (circles)o f2 0m MN-acetylcysteine. Two minutes after
the start of the measurement the cells were stimulated with 1 mM ATP.
At the end of the measurement, the traces were calibrated with the
successive addition of digitonin, EGTA and manganese. Results are
the means ± SEM of n experiments
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blocked the production of ROS in response to extracellular
ATP (down to 99±8% for KN-62 and 96±12% for oATP,
n=6). The P2X7 receptor, unlike the other P2X receptors, is
much less sensitive to ATP than to its analog, 3′-O-(4-
benzoyl)benzoyl adenosine 5′-triphosphate (BzATP). As
shown in Fig. 4, 100 μM BzATP increased the production
of ROS to a level nearly similar to the level reached by
1 mM ATP. All these results strongly suggested that P2X7
receptors were involved in the production of ROS. This
hypothesis was fully confirmed with P2X7 KO mice. As
originally shown by the group of Gabel [17] with macro-
phages, submandibular cells from these mice did not
express P2X7 receptors (data not shown). The exposure of
these cells to ATP did not increase their capacity to oxidize
DCFH (Fig. 1).
Mechanisms coupling the activation of P2X7 receptors
to the production of ROS
We have previously reported that the activation of P2X7
receptors in submandibular glands provokes a massive
uptake of extracellular calcium responsible for a sustained
increase of the intracellular concentration of the ion [18].
The incubation of the submandibular cells in the absence of
calcium but in the presence of 500 μM EGTA, a calcium
chelator, had no effect on the production of ROS in
response to ATP (P=0.6688), suggesting that ATP did not
increase the production of ROS after increasing the [Ca
2+]i
(Fig. 5, upper panel). When cells were incubated in the
presence of extracellular calcium, ionomycin, which is a
calcium ionophore, and thapsigargin, which blocks Ca
2+ -
ATPases in endoplasmic reticulum, did not increase the rate
of DCFH oxidation (92±15%, n=3, and 79±8%, n=5,
when compared to the rate before the addition of ionomycin
or thapsigargin, respectively). Under the same experi-
mental conditions, both ionomycin and thapsigargin
increased the [Ca
2+]i (data not shown). These results
confirmed that calcium ions play no role in the production
of ROS in response to ATP. There is a general consensus
that the production of ROS by monocytes/macrophages in
response to ATP is regulated by kinases [5]. Therefore,
inhibitors of various kinases were next tested (Fig. 5,
lower panel). The inhibition of the phosphatidylinositol-3
kinase by LY294002 [19] had no effect on the response to
ATP (from 182±11%, n=20, in the presence of DMSO to
199±17%, n= 1 0 ,i nt h ep r e s e n c eo f1 0 0μM LY294002).
Bisindolylmaleimide, an inhibitor of protein kinase C
dose-dependently blocked the response to ATP in the
100 nM-10 μM concentration range. Chelerythrine, another
inhibitor of protein kinase C, also inhibited the response to
1 mM ATP. PD98059, a potent, cell-permeant and selective
inhibitor of p42/44 MAP kinase [20], blocked the response
to ATP (down to 133±11%, n=10, P<0.005 in the presence
of 100 μM PD98059). Chelerythrine and PD98059 which
inhibited the production of ROS in response to ATP did not
affect the increase of the [Ca
2+]i or the uptake of ethidium
bromide provoked by the nucleotide (data not shown)
Fig. 4 Role of P2X7 receptors
on the oxidation of DCFH. Cells
preloaded with DCFH were
resuspended in HBS with 5 mM
magnesium or in HBS medium
in the absence of magnesium,
under control conditions or in
the presence of either 100 μM
ivermectin, 5 μM KN-62 or
100 μM oATP. Two minutes
after the start of the measure-
ment the cells were exposed to
the mentioned concentrations of
ATP or to 100 μM BzATP.
Results are the means ± SEM of
n experiments. **P<0.01;
***P<0.005
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by ATP stimulation
Several mechanisms (electron transport system, enzymatic
activities) could contribute to the production of ROS.
Several inhibitors were tested for their possible effect on
the oxidation of DCFH in response to ATP. The preincu-
bation of the submandibular glands with 1 μM oligomycin,
an inhibitor of the proton channel of the mitochondrial
ATPase or 1 μM FCCP, a protonophore uncoupling the
mitochondria, or with 1 mM allopurinol, an inhibitor of
xanthine oxidase, or with 1 mM N-methylarginine, an
inhibitor of nitric oxide synthase, had no effect on the
response to ATP (Fig. 6). Apocynin (100 μM), an inhibitor
of the translocation of the p47 subunit of NADPH oxidase
from the cytosol to the plasma membrane [21], fully
blocked the response to ATP (from 186±15%, n=11, in
the presence of ATP alone to 101±8%, n=4, in the
presence of ATP plus apocynin). One millimolar AEBSF,
an inhibitor of the assembly of the various subunits of
NADPH oxidase [22], or 500 μM DPI, an inhibitor of
NADPH oxidase and other flavoproteins [23], also in-
hibited the stimulation of ROS production by ATP (143±
4%, n=8, for AEBSF and 112±13%, n=4, for DPI, P<
0.05 for both inhibitors when compared to ATP plus
DMSO). AEBSF and DPI had no effect on the increase of
the [Ca
2+]i or the uptake of ethidium bromide in response to
ATP mM. Apocynin interfered with the assay of the [Ca
2+]i
with the fura-2 method. It had no effect on the uptake of
ethidium bromide provoked by ATP (data not shown).
Discussion
We have shown in this work that the rate of oxidation of
DCFH was increased when cells from submandibular
glands of control mice were exposed to ATP. It is generally
agreed that the oxidation of DCFH is secondary to the
production of ROS [24, 25]. However, this method has its
limitations: DCFH itself can generate ROS under aerobic
conditions [26, 27]. We evaluated the contribution of ROS
in the oxidation of DCFH by incubating the cells with a
ROS scavenger, N-acetylcysteine. This drug significantly
inhibited the basal increase of the fluorescence of DCFH by
about 30%. It also abolished the increase of fluorescence
provoked by ATP and inhibited the initial increase of the
[Ca
2+]i following the exposure of the submandibular cells
to ATP. The increase of the [Ca
2+]i seen after 1-min
exposure to the agonist was not affected by N-acetylcys-
teine. We have recently reported that the initial component
of the response to ATP mainly involved P2X4 receptors;
P2X7 receptors mostly contribute to the later phase of the
response [12]. The results obtained with N-acetylcysteine
suggest that this drug probably inhibited the interaction
between ATP and the P2X4 receptor, not the P2X7 receptor.
The various P2X receptors have ten cysteine residues
forming five disulfide bridges which are essential for the
receptor function or its trafficking to the plasma membrane
[28]. Our results suggest that N-acetylcysteine might reduce
some of the disulfide bridges of the P2X4 receptor and
affect the interaction between this receptor and its agonist.
Fig. 5 Intracellular pathway mediating the response to P2X7 receptors.
Upper panel: cells preloaded with DCFH were resuspended in HBS
without calcium but in the presence of 500 μME G T Ao ri nH B Sw i t h
1 mM calcium. Two minutes after the start of the measurement cells
were exposed to 1 mM ATP or 5 μM ionomycin or 10 μM thapsigargin.
Results are the means + SEM of n experiments. Lower panel:c e l l s
preloaded with DCFH were resuspended in HBS medium containing
1 mM calcium. The cells were exposed for 10 min at 25°C to control
conditions (DMSO) or to various concentrations of bisindolylmaleimide
(BIM) or to 5 μM chelerythrine or 100 μM LY294002 or to 100 μM
PD98059. Two minutes after the start of the measurement cells were
exposed to 1 mM ATP. Results are the means ± SEM of n experiments.
*P<0.05; **P<0.01; ***P<0.005
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rather than increased the basal fluorescence of DCF. This is
consistent with the results of Barroso et al. [29] who
showed that the activity of superoxide dismutase was
increased in submandibular glands from isoproterenol-
treated animals. It should however be noted that the
response to isoproterenol was probably not secondary to
the activation of the adrenergic receptor and the stimulation
of adenylate cyclase since it was reproduced with the
inactive isomer of isoproterenol and since forskolin, which
is a general activator of adenylate cyclase, had no effect on
the fluorescence of DCF. These results suggest that
isoproterenol itself might have antioxidative properties
thanks to its phenol group [30].
The production of ROS in response to extracellular ATP
required high concentrations (higher than 100 μM) of the
nucleotide. The response to ATP was blocked by extracel-
lular magnesium, KN-62 or oATP; it was reproduced by
BzATP and was not sensitive to U73122, an inhibitor of
PLC, or to ivermectin, an enhancer of the activation of
P2X4 receptors by ATP. Importantly, it was not reproduced
in cells from P2X7 receptors KO mice. All these results
suggest that the production of ROS in response to ATP is
mediated by P2X7 receptors. These receptors are expressed
in exocrine glands and especially in submandibular glands
[12]. They form a non-selective cation channel and their
occupancy leads to a massive uptake of extracellular
calcium and the increase of the [Ca
2+]i. In a secondary
step, these receptors form a pore which is permeant to
ethidium bromide [10]. The response to ATP was not
affected by the removal of extracellular calcium, suggesting
that the production of ROS was not secondary to the
increase of the [Ca
2+]i. This is consistent with the results
obtained with carbachol. This muscarinic agonist transient-
ly increased the [Ca
2+]i without modifying the production
of ROS. Thapsigargin and ionomycin, which both pro-
voked a sustained increase of the [Ca
2+]i, had no effect on
the rate of DCFH oxidation, confirming that calcium ions
are not involved in the stimulation of ROS production. The
cascade leading from receptor occupancy to ROS produc-
tion probably involved protein kinase C and p42/44 MAP
kinase since inhibitors of these two enzyme activities
decreased the production of ROS in response to ATP
without affecting the non-selective cation channel or the
pore coupled to the P2X7 receptors. This is in agreement
with the results of Bradford and Soltoff who nicely
demonstrated the involvement of protein kinase C and
p42/44 MAP kinase activation in the cellular signalling
pathway triggered by P2X7 activation in parotid glands
[31]. It should however be mentioned that the activation of
protein kinase C is necessary but probably not sufficient to
stimulate the production of ROS since in our hands the
incubation of the cells with a phorbol ester (PMA) which
activates protein kinase C had no effect on fluorescence of
DCFH (data not shown). The combination of PMA with
ionomycin was also without effect on the production of
ROS. These results are consistent with the results observed
with carbachol: the muscarinic agonist which increases the
activity of protein kinase C [31] has no effect on the
production of ROS (vide supra). It should be recalled that,
contrary to carbachol, the responses triggered by agonists of
the P2X7 receptors are numerous and pleiotropic. These
agonists not only increase the phosphorylation of proteins
but also provoke major changes in the ionic composition of
Fig. 6 Mechanism involved in
the oxidation of DCFH by ATP.
Cells preloaded with DCFH
were resuspended in HBS me-
dium containing 1 mM calcium.
The cells were exposed for 10
min at 25°C to control condi-
tions (DMSO) or to the antago-
nists mentioned in the figure.
Two minutes after the start of
the measurement cells were ex-
posed to 1 mM ATP. Results are
the means ± SEM of n experi-
ments. *P<0.05; **P<0.01
Purinergic Signalling (2008) 4:347–355 353the cytosol (sodium, potassium, calcium, protons), in the
metabolism of phospholipids or in the permeability of the
plasma membrane [32].
After the exclusion of several sources of ROS (mito-
chondria, xanthine oxidase, NO synthase) in the response to
ATP, the possibility remained that NADPH oxidase or one
of its isoforms might contribute to the response to
extracellular ATP. Indeed it has been shown that exocrine
glands among which submandibular glands express one
of the homologs of the gp91
phox subunit of NADPH oxidase,
the “dual” oxidase 2 (Duox2) [33]. Duox2 not only contains
the NADPH oxidase domain but also a domain that is
homologous to heme-containing peroxidases such as myelo-
peroxidase and lactoperoxidase, hence its name [34]. When
compared to the gp91
phox, Duox2 has a large N-terminal
e x t e n s i o nc o m p r i s i n gt w oE F - h a n dm o t i f s ,w h i c he x p l a i n si t s
regulation by calcium ions [35]. Considering that calcium
had no effect on the production of ROS by ATP, Duox2 was
probably not involved in this response. Three inhibitors of
NADPH oxidase, DPI or apocynin or AEBSF, inhibited the
production of ROS but not the increase of the [Ca
2+]i or the
uptake of ethidium bromide in response to extracellular ATP.
From these results we conclude that NADPH oxidase is the
enzyme responsible for the production of ROS by subman-
dibular glands exposed to ATP.
P2X7 receptors are thus coupled to the production of ROS
not only in phagocytic cells [4, 5, 36] but also in non-
phagocytic cells (this report). In both cell types the NADPH
oxidase is the source of these ROS, but the signalling
pathway activating this enzyme might differ among these
cells. Parvathenani et al. [36]r e p o r t e dt h a ti nm i c r o g l i a lc e l l s
the response to ATP was also calcium dependent; the MAP
kinase mediating the response to ATP was not attenuated by
PD98059, an inhibitor of p42/44 MAP kinase, but by
SB203580, an inhibitor of p38 MAP kinase; it was more
sensitive to an inhibitor of PI3 kinase. In phagocytic cells
ROS participate in host defence by killing invading micro-
organisms and by triggering the release of cytokines [37]. In
salivary glands, the production of ROS in response to
purinergic agonists (this report) and the secretion of
peroxidase in response to autonomic agonists (muscarinic,
adrenergic, tachykininergic or VIPergic) [38] by the cells
might contribute to the production of hydrogen peroxide
which could kill pathogens present in the oral cavity [7].
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